Chugai Pharmaceutical Statistics Share Statistics Chugai Pharmaceutical has 3.29B
shares outstanding. The number of shares has increased by 0.01%
in one year.
Shares Outstanding 3.29B Shares Change (YoY) 0.01% Shares Change (QoQ) 0.01% Owned by Institutions (%) 0.01% Shares Floating 639.77M Failed to Deliver (FTD) Shares 68,193 FTD / Avg. Volume 33.52%
Short Selling Information The latest short interest is 7.66K, so 0% of the outstanding
shares have been sold short.
Short Interest 7.66K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 29.37 and the forward
PE ratio is 0.18.
Chugai Pharmaceutical's PEG ratio is
1.54.
PE Ratio 29.37 Forward PE 0.18 PS Ratio 9.72 Forward PS 0.1 PB Ratio 5.98 P/FCF Ratio 28.96 PEG Ratio 1.54
Financial Ratio History Enterprise Valuation Chugai Pharmaceutical has an Enterprise Value (EV) of 5,146.7B.
EV / Sales 4.4 EV / EBITDA 9.5 EV / EBIT 11.5 EV / FCF 13.11
Financial Position The company has a current ratio of 5.53,
with a Debt / Equity ratio of 0.
Current Ratio 5.53 Quick Ratio 4.7 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -527.75
Financial Efficiency Return on Equity is 20.37% and Return on Invested Capital is 20.16%.
Return on Equity 20.37% Return on Assets 17.54% Return on Invested Capital 20.16% Revenue Per Employee $232.91M Profits Per Employee $77.06M Employee Count 5,026 Asset Turnover 0.53 Inventory Turnover 1.41
Taxes Income Tax 155.72B Effective Tax Rate 28.68%
Stock Price Statistics The stock price has increased by -2.09% in the
last 52 weeks. The beta is 0.69, so Chugai Pharmaceutical's
price volatility has been higher than the market average.
Beta 0.69 52-Week Price Change -2.09% 50-Day Moving Average 24.77 200-Day Moving Average 23.91 Relative Strength Index (RSI) 31.18 Average Volume (20 Days) 203,451
Income Statement In the last 12 months, Chugai Pharmaceutical had revenue of 1,170.6B
and earned 387.32B
in profits. Earnings per share was 117.7.
Revenue 1,170.6B Gross Profit 831.2B Operating Income 542B Net Income 387.32B EBITDA 542B EBIT 542B Earnings Per Share (EPS) 117.7
Full Income Statement Balance Sheet The company has 540.2B in cash and 0 in
debt, giving a net cash position of 540.2B.
Cash & Cash Equivalents 540.2B Total Debt n/a Net Cash n/a Retained Earnings n/a Total Assets 2,060.2B Working Capital 1,185.9B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 447.6B
and capital expenditures -54.9B, giving a free cash flow of 392.7B.
Operating Cash Flow 447.6B Capital Expenditures -54.9B Free Cash Flow 392.7B FCF Per Share 119.33
Full Cash Flow Statement Margins Gross margin is 71.01%, with operating and profit margins of 46.3% and 33.09%.
Gross Margin 71.01% Operating Margin 46.3% Pretax Margin 46.39% Profit Margin 33.09% EBITDA Margin 46.3% EBIT Margin 46.3% FCF Margin 33.55%
Dividends & Yields CHGCY pays an annual dividend of $0.24,
which amounts to a dividend yield of 1.11%.
Dividend Per Share $0.24 Dividend Yield 1.11% Dividend Growth (YoY) -16.22% Payout Ratio 29.97% Earnings Yield 3.41% FCF Yield 6.91%
Dividend Details Analyst Forecast Currently there are no analyst rating for CHGCY.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $2942.5 Lynch Upside 14183.98% Graham Number 2473.94 Graham Upside 11909.42%
Stock Splits The last stock split was on Jul 6, 2020. It was a
forward
split with a ratio of 12:1.
Last Split Date Jul 6, 2020 Split Type forward Split Ratio 12:1
Scores Altman Z-Score 3.22 Piotroski F-Score 5
